Overview
Tirzepatide is a research-grade peptide compound that has attracted significant attention in the scientific community for its role in metabolic regulation. Dual GIP/GLP-1 receptor agonist. Superior metabolic pathway regulation research compound.
This compound belongs to the metabolic category of research peptides and has been the subject of numerous preclinical investigations. Its unique molecular properties make it a valuable tool for researchers exploring novel therapeutic pathways.
Tirzepatide activates both GIP and GLP-1 receptors simultaneously, producing additive effects on insulin secretion, satiety signaling, and lipid oxidation beyond single-agonist compounds. The growing body of published literature continues to expand our understanding of this compound's potential applications in laboratory settings.
Mechanism of Action
Tirzepatide activates both GIP and GLP-1 receptors simultaneously, producing additive effects on insulin secretion, satiety signaling, and lipid oxidation beyond single-agonist compounds.
The signaling pathways activated by Tirzepatide continue to be mapped through proteomic and transcriptomic analyses. Current research focuses on identifying the specific receptor subtypes and downstream effectors responsible for the observed biological responses. Understanding these molecular interactions is critical for advancing the compound from preclinical investigation toward potential translational applications.
Research Areas
- Metabolic pathway regulation research
- Glucose homeostasis and insulin sensitivity
- Energy expenditure and lipid metabolism
- Satiety signaling mechanisms
- Metabolic flux analysis
Compound Specifications
| CAS Number | 2023788-19-2 |
| Purity | ≥99% HPLC-MS verified |
| Storage | −20 °C. ≥18 months lyophilised. |
| Category | Metabolic |
| Price | €161 |
| Format | 40mg lyophilised |
Available Formats
- 5mg vial
- 10mg vial
- 40mg bulk
Dissolution
Use our dilution calculator for precise concentration calculations.